TY - JOUR
T1 - Prevalence, characteristics, and impact of frailty in patients with functional tricuspid regurgitation
AU - Saji, Mike
AU - Yoshikawa, Tsutomu
AU - Takayama, Morimasa
AU - Izumi, Yuki
AU - Takamisawa, Itaru
AU - Okamura, Tomonori
AU - Shimizu, Hideyuki
AU - Lim, David Scott
AU - Latib, Azeem
AU - Isobe, Mitsuaki
AU - Fukuda, Keiichi
N1 - Funding Information:
From the 1Department of Cardiology, Sakakibara Heart Institute, Tokyo, Japan, 2Department of Cardiology, Keio University School of Medicine, Tokyo, Japan, 3Department of Preventive Medicine and Public Health, Keio University School of Medicine, Tokyo, Japan, 4Department of Cardiothoracic Surgery, Keio University School of Medicine, Tokyo, Japan, 5Advanced Cardiac Valve Center, Department of Medicine, Division of Cardiovascular Medicine, University of Virginia, Charlottesville, USA and 6Department of Cardiology, Montefiore Medical Center, Bronx, USA. This research was supported by the Mitsui Life Social Welfare Foundation and Sakakibara Heart Institute research grant. Address for correspondence: Mike Saji, MD, Department of Cardiology, Sakakibara Heart Institute, 3-16-1 Asahi-cho, Fuchu, Tokyo 183-0003, Japan.
Publisher Copyright:
© 2021, International Heart Journal Association. All rights reserved.
PY - 2021
Y1 - 2021
N2 - Little is known as regards frailty in patients with functional tricuspid regurgitation (FTR). Thus, in this study, we aimed to investigate the prevalence, characteristics, and impact of frailty on patients with severe FTR. This prospective study included 110 consecutive patients with severe FTR who were assessed via transtho-racic echocardiography at an outpatient clinic. Patients were dichotomized using short physical performance bat-tery (SPPB). To better understand the whole picture of frailty in patients with FTR, other frailty scales were also assessed (frailty checklist, clinical frailty scale, gait speed, and Columbia frailty scale). The primary end-point was the combination of all-cause mortality and heart failure hospitalization. According to each definition of frailty, 28%-46% were identified to be frail. Those with SPPB score of < 9 were older, had greater New York Heart Association (NYHA) functional classification, and had lower albumin level and estimated glomerular filtration rate compared with those with SPPB score of ≥9. They also have smaller tricuspid valve coaptation depth and worse right ventricular fractional area change (RV-FAC) than those with SPPB score of ≥9 despite having similar TR severity. The primary endpoint at 1 year was noted in 31% of patients. The SPPB score has excellent discriminatory performance for predicting the primary endpoint (area under the curve 0.82, 95% confidence interval [CI] 0.76-0.91) in receiver operating characteristic analysis and was independently associated with the primary endpoint after adjustment in multivariate analysis (adjusted haz-ard ratio 0.81, 95% CI, 0.73-0.90; P < 0.001). Frailty has been widely prevalent in the elderly patient population with FTR; in fact, it has been deter-mined to be strong parameter for poor outcomes.
AB - Little is known as regards frailty in patients with functional tricuspid regurgitation (FTR). Thus, in this study, we aimed to investigate the prevalence, characteristics, and impact of frailty on patients with severe FTR. This prospective study included 110 consecutive patients with severe FTR who were assessed via transtho-racic echocardiography at an outpatient clinic. Patients were dichotomized using short physical performance bat-tery (SPPB). To better understand the whole picture of frailty in patients with FTR, other frailty scales were also assessed (frailty checklist, clinical frailty scale, gait speed, and Columbia frailty scale). The primary end-point was the combination of all-cause mortality and heart failure hospitalization. According to each definition of frailty, 28%-46% were identified to be frail. Those with SPPB score of < 9 were older, had greater New York Heart Association (NYHA) functional classification, and had lower albumin level and estimated glomerular filtration rate compared with those with SPPB score of ≥9. They also have smaller tricuspid valve coaptation depth and worse right ventricular fractional area change (RV-FAC) than those with SPPB score of ≥9 despite having similar TR severity. The primary endpoint at 1 year was noted in 31% of patients. The SPPB score has excellent discriminatory performance for predicting the primary endpoint (area under the curve 0.82, 95% confidence interval [CI] 0.76-0.91) in receiver operating characteristic analysis and was independently associated with the primary endpoint after adjustment in multivariate analysis (adjusted haz-ard ratio 0.81, 95% CI, 0.73-0.90; P < 0.001). Frailty has been widely prevalent in the elderly patient population with FTR; in fact, it has been deter-mined to be strong parameter for poor outcomes.
KW - All-cause mortality
UR - http://www.scopus.com/inward/record.url?scp=85120409738&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85120409738&partnerID=8YFLogxK
U2 - 10.1536/ihj.21-273
DO - 10.1536/ihj.21-273
M3 - Article
C2 - 34853221
AN - SCOPUS:85120409738
SN - 1349-2365
VL - 62
SP - 1280
EP - 1286
JO - International Heart Journal
JF - International Heart Journal
IS - 6
ER -